| Missing Links?: 9 Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 336,
Authors: 449,
Journals: 71,
Outer References: 6420,
Words: 1172
Collection span: 1977 - 2006
View: Overview. Sorted by first author.
Page 4 of 4: [ 1 2 3 4 ]
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 301 | 0 | 0 | 196 1999 ESSENTIALS GLYCOBIOL VARKI A; Esko J; Cummings R; Freeze HH; Hart GW; et al. Essentials of Glycobiology | 12 | 384 |
| 302 | 0 | 0 | 209 1999 SCIENCE 283 (5403): 791-792 Varki A Disappearing physician-scientists | 0 | 2 |
| 303 | 0 | 0 | 210 2000 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 219: U238-U238 Varki A; Angata T; van der Linden EB Structural diversity in the sialic acids: Implications for the recognition of biological ligands by the Siglec family of mammalian lectins. | 0 | 0 |
| 304 | 0 | 0 | 211 2000 AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY : 309-309 Varki A Human genetic loss of CMP-sialic acid hydroxylase occurred after the last common ancestor with the great apes. | 0 | 0 |
| 305 | 5 | 71 | 213 2000 GENOME RESEARCH 10 (8): 1065-1070 Varki A A chimpanzee genome project is a biomedical imperative | 12 | 32 |
| 306 | 14 | 127 | 232 2001 BIOCHIMIE 83 (7): 615-622 Varki A N-glycolylneuraminic acid deficiency in humans | 0 | 13 |
| 307 | 8 | 53 | 234 2001 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 34 (6): 711-717 Varki A; Varki NM P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications | 1 | 18 |
| 308 | 22 | 153 | 253 2001 YEARBOOK OF PHYSICAL ANTHROPOLOGY, VOL 44 44: 54-69 Varki A Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution | 0 | 4 |
| 309 | 7 | 8 | 259 2002 GLYCOBIOLOGY 12 (10): 653-653 Varki A Evolutionary considerations in understanding siglec biology | 0 | 0 |
| 310 | 0 | 8 | 267 2002 NATURE MEDICINE 8 (5): 437-439 Varki A; Rosenberg LE Emerging opportunities and career paths for the young physician-scientist | 0 | 19 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 311 | 1 | 12 | 268 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99 (2): 543-545 Varki A Six blind men and the elephant - the many faces of heparan sulfate | 0 | 2 |
| 312 | 0 | 0 | 274 2002 YEARBOOK OF PHYSICAL ANTHROPOLOGY 44: 54-69 VARKI A Loss of N-Glycolylneuraminic acid in Humans: Mechanisms, Consequences and Implications for Hominid Evolution | 12 | 13 |
| 313 | 0 | 0 | 281 2003 FASEB JOURNAL 17 (5): A1182-A1182 Varki A; Wahrenbrock M; Stevenson JL; Le D; Borsig L; et al. Pathological interactions of selectins with carcinoma-derived glycan ligands | 0 | 0 |
| 314 | 0 | 2 | 293 2003 NATURE 426 (6965): 383-383 Varki A Open access: the JCI has already shown it works | 0 | 1 |
| 315 | 14 | 31 | 298 2004 BIOASTRONOMY 2002: LIFE AMONG THE STARS (213): 343-348 Varki A Genetic differences between humans and great apes implications for the evolution of humans. | 0 | 0 |
| 316 | 1 | 6 | 299 2004 BLOOD 104 (10): 3005-3005 Varki A Glycosylation engineering enhances stem cell homing | 0 | 0 |
| 317 | 6 | 6 | 308 2004 GLYCOBIOLOGY 14 (11): 1070-1070 Varki A; Varki NM Histochemistry in comparative glycomics: Surveying the forest before examining trees | 0 | 0 |
| 318 | 3 | 15 | 317 2004 NATURE GENETICS 36 (10): 1034-1036 Varki A How to make an ape brain | 3 | 6 |
| 319 | 0 | 0 | 325 2005 FASEB JOURNAL 19 (5): A1712-A1712 Varki A Biology and evolution of the Siglecs: A decade of progress | 0 | 0 |
| 320 | 19 | 133 | 326 2005 GENOME RESEARCH 15 (12): 1746-1758 Varki A; Altheide TK Comparing the human and chimpanzee genomes: Searching for needles in a haystack | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 321 | 34 | 262 | 336 2006 GLYCOBIOLOGY 16 (1): 1R-27R Varki A; Angata T Siglecs - the major subfamily of I-type lectins | 0 | 0 |
| 322 | 0 | 0 | 282 2003 FASEB JOURNAL 17 (5): A1359-A1360 Varki N; Brinkman-van der Linden E; Hayakawa T; Wiggleton L; Benirschke K; et al. Is the expression of SigLec 6 on placental trophoblast associated with onset of labor of human labor | 0 | 0 |
| 323 | 0 | 0 | 202 1999 GLYCOBIOLOGY 9 (10): 1115-1116 Varki NM; Priatel J; Chui D; Varki A; Marth J Histologic and lectin analysis of genetically altered mice for deficiencies in specific sialyltransferases | 0 | 0 |
| 324 | 0 | 1 | 237 2001 GLYCOBIOLOGY 11 (10): 883-883 Varki NM; Cheriyan M; Brinkman-Van der Linden ECM; Gagneux P; Varki A Upregulation of epithelial and erythrocyte cell surface expression of alpha 2-6 linked sialic acids was a specific change during human evolution | 0 | 1 |
| 325 | 10 | 116 | 273 2002 SEMINARS IN THROMBOSIS AND HEMOSTASIS 28 (1): 53-66 Varki NM; Varki A Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: Rationale for clinical studies in humans | 4 | 31 |
| 326 | 0 | 0 | 280 2003 FASEB JOURNAL 17 (5): A1177-A1177 Varki NM; Karazuba J; Verhagen A; Kim YL; Varki A Different strains of inbred mice show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation. | 0 | 0 |
| 327 | 0 | 0 | 288 2003 GLYCOBIOLOGY 13 (11): 897-897 Verhagen A; Kim YL; Varki A; Varki NM Tissue-specific alterations in sialylation and sialic acid 9-O-acetylation in rats and mice. Evidence for species-specific rapid evolution of sialylation phenotypes | 0 | 0 |
| 328 | 11 | 88 | 291 2003 JOURNAL OF CLINICAL INVESTIGATION 112 (6): 853-862 Wahrenbrock M; Borsig L; Le D; Varki N; Varki A Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas | 1 | 10 |
| 329 | 0 | 0 | 283 2003 GLYCOBIOLOGY 13 (11): 834-834 Wahrenbrock MG; Borsig L; Le D; Varki N; Varki A Selectin-mucin interactions: A probable molecular explanation for the association of Trousseau's syndrome with mucinous adenocarcinomas | 0 | 0 |
| 330 | 0 | 0 | 303 2004 BLOOD 104 (11): 230A-230A Wahrenbrock MG; Varki A Multiple hepatic clearance receptors facilitate elimination of secretory mucins that can enter the bloodstream in pathological states and generate platelet-rich microthrombi | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 331 | 0 | 0 | 222 2000 GLYCOBIOLOGY 10 (10): 1095-1095 Wang LC; Varki A; Esko JD Structural requirements for heparin binding to P-and L-selectin | 0 | 0 |
| 332 | 0 | 0 | 238 2001 GLYCOBIOLOGY 11 (10): 891-891 Wang LC; Varki A; Esko JD Structural requirements of heparin-induced leukocytosis | 0 | 0 |
| 333 | 6 | 76 | 263 2002 JOURNAL OF CLINICAL INVESTIGATION 110 (1): 127-136 Wang LC; Brown JR; Varki A; Esko JD Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L-and P-selectins | 2 | 54 |
| 334 | 0 | 0 | 284 2003 GLYCOBIOLOGY 13 (11): 883-883 Zhang M; Varki A Sialic acids and CD22 function: Exploring the effects on interactions with CD45 and sIgM, constitutive endocytosis, and antibody-induced endocytosis | 0 | 0 |
| 335 | 9 | 47 | 307 2004 GLYCOBIOLOGY 14 (11): 939-949 Zhang M; Varki A Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis | 0 | 4 |
| 336 | 6 | 63 | 78 1991 JOURNAL OF CELL BIOLOGY 115 (2): 557-564 ZHOU Q; MOORE KL; SMITH DF; VARKI A; MCEVER RP; et al. THE SELECTIN GMP-140 BINDS TO SIALYLATED, FUCOSYLATED LACTOSAMINOGLYCANS ON BOTH MYELOID AND NONMYELOID CELLS | 6 | 171 |